Middle East & Africa Osteoarthritis Therapy Market to 2030 - By Size, Share, Growth by End User and Forecast

The Middle East & Africa osteoarthritis therapy market was valued at US$ 460.00 million in 2022 and is expected to reach US$ 762.98 million by 2030; it is estimated to register a CAGR of 6.5% from 2022 to 2030.

Rising Prevalence of Osteoarthritis Bolsters Middle East & Africa Osteoarthritis Therapy Market

Globally, OA affects more than 500 million people accounting 7% of the world's population according to the CDC report. It represents a major cause of long-term disability. Additionally, osteoarthritis is also more prevalent among athletes and people who sustain joint injury or trauma. Moreover, it is more prevalent among women, accounting for 60% of global osteoarthritis cases. According to the World Health Organization (WHO) report, osteoarthritis is more prevalent among older population. Also, OA can affect anyone, but the condition is most common in adults over 40 years age. Also, The World Health Organization report further reveals that, about 73% of are living with OA are older than 55 years and 60% are female. Thus, with the rising prevalence of OA, new therapy options such as biological therapy are gaining attention worldwide. Platelet-rich plasma (PRP) therapy is one example that has emerged as a promising treatment for patients suffering from OA. PRP enhances tissue recovery by catalyzing the body's natural healing and tissue repair processes.

Transcutaneous Electrical Nerve Stimulation (TENS) is another example of a treatment option to treat OA. TENS helps minimize acute and chronic pains by reducing the need for medications. Therefore, rising prevalence of OA accelerates demand for innovative treatment options, reducing the dependency on medications in the coming years.

Middle East & Africa Osteoarthritis Therapy Market Overview

Middle East & Africa region is segmented as Saudi Arabia, South Africa, UAE, and the Rest of Middle East & Africa countries. The rising obesity rates, alteration in lifestyles, and dietary patterns are the most influential factors responsible for accelerating demand for osteoarthritis drugs in the Middle East & Africa region. According to the National Institute of Health (NIH) report, osteoarthritis is the most prevalent form of arthritis. In South Africa, in urban settings, it accounted for 55.1%; in rural settings, it ranged from 29.5% to 29.7%, reaching up to 82.7% among the population over 65 years. Physicians suggest several therapeutic options to treat osteoarthritis. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. Therefore, the availability of treatment options for osteoarthritis is the major factor responsible for the market growth during the 2022-2030.

Middle East & Africa Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

Get more information on this report

Middle East & Africa Osteoarthritis Therapy Strategic Insights

Strategic insights for the Middle East & Africa Osteoarthritis Therapy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-osteoarthritis-therapy-market-strategic-framework.webp

Get more information on this report

Middle East & Africa Osteoarthritis Therapy Report Scope

Report Attribute	Details
Market size in 2022	US$ 460.00 Million
Market Size by 2030	US$ 762.98 Million
Global CAGR (2022 - 2030)	6.5%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Therapy Type Transcutaneous Electrical Nerve Stimulation Occupational Therapy Physical Therapy Platelet-Rich Plasma Therapy & Stromal Vascular Fraction Prolotherapy By Disease Indication Knee Osteoarthritis Spine Osteoarthritis Foot & Ankle Osteoarthritis Shoulder Osteoarthritis Hand Osteoarthritis
Regions and Countries Covered	Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Estar Technologies Ltd Zimmer Biomet Holdings Inc DePuy Synthes Inc Bioventus Inc Omron Healthcare Inc Medi GmbH & Co KG

Get more information on this report

Middle East & Africa Osteoarthritis Therapy Regional Insights

The geographic scope of the Middle East & Africa Osteoarthritis Therapy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

geography/middle-east-and-africa-osteoarthritis-therapy-market-geography.webp

Get more information on this report

Middle East & Africa Osteoarthritis Therapy Market Segmentation

The Middle East & Africa osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the Middle East & Africa osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the Middle East & Africa osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Middle East & Africa osteoarthritis therapy market in 2022.

Based on end user, the Middle East & Africa osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Middle East & Africa osteoarthritis therapy market in 2022.

By country, the Middle East & Africa osteoarthritis therapy market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa osteoarthritis therapy market share in 2022.

Estar Technologies Ltd, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, and Medi GmbH & Co KG are some of the leading companies operating in the Middle East & Africa osteoarthritis therapy market.

Identical Market Reports with other Region/Countries